Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
00003-7125-11 - NIVOLUMAB-RELATLIMAB RMBW 240 MG-80 MG/20 ML SOL (OTHER 4967152) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved July 1, 2026 , from http://ppman.hank.ai/transparency/procedure/4967152/by-state?code_type=OTHER
“00003-7125-11 - NIVOLUMAB-RELATLIMAB RMBW 240 MG-80 MG/20 ML SOL (OTHER 4967152) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/4967152/by-state?code_type=OTHER. Accessed
July 1, 2026 .
“00003-7125-11 - NIVOLUMAB-RELATLIMAB RMBW 240 MG-80 MG/20 ML SOL (OTHER 4967152) by State,” HANK Price Transparency ,
accessed July 1, 2026 ,
http://ppman.hank.ai/transparency/procedure/4967152/by-state?code_type=OTHER.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
OTHER · across United States
4967152 — 00003-7125-11 - Nivolumab-relatlimab Rmbw 240 Mg-80 Mg/20 Ml Sol
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$30,488
National median
$25,587 – $32,605
IQR (p25 – p75)
1
hospitals filing
1
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 4967152 (OTHER), with interquartile range
State Median p25 p75
CO $30,488 $25,587 $32,605